Cargando…

Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent

Tea Tree oil (TTO) is well known for its numerous good properties but might be also irritating or toxic when used topically or ingested, thus limiting the number of possible applications in Humans. The aim of the study was to characterize the antimicrobial spectrum as well as the toxicity of Titrole...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansen, Bianca, Duval, Raphaël E., Sergere, Jean-Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400619/
https://www.ncbi.nlm.nih.gov/pubmed/32650521
http://dx.doi.org/10.3390/antibiotics9070391
_version_ 1783566405350719488
author Johansen, Bianca
Duval, Raphaël E.
Sergere, Jean-Christophe
author_facet Johansen, Bianca
Duval, Raphaël E.
Sergere, Jean-Christophe
author_sort Johansen, Bianca
collection PubMed
description Tea Tree oil (TTO) is well known for its numerous good properties but might be also irritating or toxic when used topically or ingested, thus limiting the number of possible applications in Humans. The aim of the study was to characterize the antimicrobial spectrum as well as the toxicity of Titroleane™, a new anti-infective agent obtained from TTO but cleared of its toxic monoterpenes part. The susceptibility to Titroleane™ of various pathogens (bacteria and fungi) encountered in animal and human health was studied in comparison with that of TTO. Antimicrobial screening was carried out using the broth microdilution method. Activities against aerobic, anaerobic, fastidious and non-fastidious microorganisms were performed. For all microorganisms tested, the MIC values for Titroleane™ ranged from 0.08% to 2.5%, except for Campylobacter jejuni, and Aspergillus niger. In particular, Titroleane™ showed good efficacy against skin and soft tissue infection pathogens, such as methicillin resistant Staphylococcus aureus (MRSA), intra-abdominal infections and oral pathogens, as well as fish farming pathogens. Toxicity testing showed little and similar cytotoxicities between TTO and Titroleane™ of 37% and 23%, respectively at a concentration of 0.025% (v/v). Finally, we demonstrated that the antimicrobial activity of Titroleane™ is similar to that of TTO.
format Online
Article
Text
id pubmed-7400619
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-74006192020-08-07 Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent Johansen, Bianca Duval, Raphaël E. Sergere, Jean-Christophe Antibiotics (Basel) Article Tea Tree oil (TTO) is well known for its numerous good properties but might be also irritating or toxic when used topically or ingested, thus limiting the number of possible applications in Humans. The aim of the study was to characterize the antimicrobial spectrum as well as the toxicity of Titroleane™, a new anti-infective agent obtained from TTO but cleared of its toxic monoterpenes part. The susceptibility to Titroleane™ of various pathogens (bacteria and fungi) encountered in animal and human health was studied in comparison with that of TTO. Antimicrobial screening was carried out using the broth microdilution method. Activities against aerobic, anaerobic, fastidious and non-fastidious microorganisms were performed. For all microorganisms tested, the MIC values for Titroleane™ ranged from 0.08% to 2.5%, except for Campylobacter jejuni, and Aspergillus niger. In particular, Titroleane™ showed good efficacy against skin and soft tissue infection pathogens, such as methicillin resistant Staphylococcus aureus (MRSA), intra-abdominal infections and oral pathogens, as well as fish farming pathogens. Toxicity testing showed little and similar cytotoxicities between TTO and Titroleane™ of 37% and 23%, respectively at a concentration of 0.025% (v/v). Finally, we demonstrated that the antimicrobial activity of Titroleane™ is similar to that of TTO. MDPI 2020-07-08 /pmc/articles/PMC7400619/ /pubmed/32650521 http://dx.doi.org/10.3390/antibiotics9070391 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Johansen, Bianca
Duval, Raphaël E.
Sergere, Jean-Christophe
Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent
title Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent
title_full Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent
title_fullStr Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent
title_full_unstemmed Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent
title_short Antimicrobial Spectrum of Titroleane™: A New Potent Anti-Infective Agent
title_sort antimicrobial spectrum of titroleane™: a new potent anti-infective agent
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400619/
https://www.ncbi.nlm.nih.gov/pubmed/32650521
http://dx.doi.org/10.3390/antibiotics9070391
work_keys_str_mv AT johansenbianca antimicrobialspectrumoftitroleaneanewpotentantiinfectiveagent
AT duvalraphaele antimicrobialspectrumoftitroleaneanewpotentantiinfectiveagent
AT sergerejeanchristophe antimicrobialspectrumoftitroleaneanewpotentantiinfectiveagent